Key terms
About FEMY
Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive healthcare. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in Suwanee, GA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest FEMY news
Apr 18
8:37am ET
Femasys CEO meets with members of Congress to raise awareness
Apr 02
3:45pm ET
Femasys: A Buy Rating on Innovative Reproductive Solutions and Market Expansion Potential
Apr 01
6:05am ET
Femasys price target raised to $12 from $10 at H.C. Wainwright
Mar 21
2:30pm ET
Analysts Offer Insights on Healthcare Companies: Femasys (FEMY) and NextCure (NXTC)
Mar 21
12:45pm ET
Femasys participates in a conference call with JonesResearch
Mar 21
11:08am ET
Femasys participates in a conference call with JonesResearch
Mar 21
6:31am ET
Analysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BioNTech SE (BNTX)
Mar 20
8:16am ET
Femasys announces topline data from trial of FemaSeed for infertility
Mar 06
9:04am ET
Femasys completes the first in-office commercial procedure with FemaSeed
Feb 28
9:32am ET
Femasys Reveals Corporate Update and FDA-Cleared Infertility Solution
Feb 28
9:03am ET
Femasys’ FemaSeed to serve as first-line therapeutic option
Feb 23
9:04am ET
Alabama decision could spur interest in Femasys, says JonesResearch
Feb 07
4:18am ET
Femasys Welcomes New Chief Commercial Officer Mr. Spector
Feb 06
8:50am ET
Femasys appoints Spector as CCO
Jan 26
8:09am ET
Femasys begins enrollment for FemBloc trial
Jan 23
8:33am ET
Femasys begins FemBloc trial enrollment at University of Utah
No recent press releases are available for FEMY
FEMY Financials
Key terms
Ad Feedback
FEMY Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
FEMY Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range